Main Article Content

Abstract

A series of tetracyclic thiazepine based pyrazoles (6a-j) have been synthesized and evaluated for antibacterial and antifungal activities. The newly synthesized compounds have been characterized by IR, 1H & 13C NMR, mass and elemental analyses. Compounds 6b (2-OCH3) and 6c (4-OCH3) have shown promising antibacterial, and 6g (3-NO2), 6f (2-NO2) and 6d (3,4-diOCH3) exhibited excellent an antifungal activity against standard drugs.

Keywords

Thiazepine Pyrazole Cyclization Antimicrobial activity

Article Details

How to Cite
B. Hirani, J., Pandya, M., & B. Koradiya, S. (2020). Synthesis, Spectral Analysis and Antibacterial Screening of Tetracyclic Thiazepine Based Pyrazole Derivatives. Asian Journal of Organic & Medicinal Chemistry, 5(4), 283–288. https://doi.org/10.14233/ajomc.2020.AJOMC-P281

References

  1. A.K. Singh, Synthesis and Antimicrobial Activity of Azepine Analogue of Lignan, J. Nep. Chem. Soc., 29, 44 (2013); https://doi.org/10.3126/jncs.v29i0.9236
  2. N.A. El-Sayed, F.M. Awadallah, N.A. Ibrahim and M.T. El-Saadi, Synthesis, Anti-inflammatory and Ulcerogenicity Studies of Some Substituted Pyrimido[1,6-a]azepine Derivatives, Eur. J. Med. Chem., 45, 3147 (2010); https://doi.org/10.1016/j.ejmech.2010.04.005
  3. W.B. Zhang, R.B. Han, W. Zhang, R.S. Jiang and F.Y. Piao, Synthesis and Anticonvulsant Activity of 8-Alkoxy-5,6-dihydro-4H-benzo[f]-[1,2,4]triazolo[4,3-a]azepine Derivatives, Med. Chem. Res., 21, 2587 (2012); https://doi.org/10.1007/s00044-011-9771-5
  4. H. Turner, Spiroindolone NITD609 is a Novel Antimalarial Drug that Targets the P-type ATPase PfATP4, Future Med. Chem., 8, 227 (2016); https://doi.org/10.4155/fmc.15.177
  5. A.K. Ghosh and D.D. Anderson, Tetrahydrofuran, Tetrahydropyran, Triazoles and Related Heterocyclic Derivatives as HIV-Protease Inhibitors, Future Med. Chem., 3, 1181 (2011); https://doi.org/10.4155/fmc.11.68
  6. X. Pan, L. Tao, M. Ji, X. Chen and Z. Liu, Synthesis and SAR of Novel Capsazepine Analogs with Significant Anti-cancer Effects in Multiple Cancer Types, Bioorg. Med. Chem. Lett., 28, 866 (2018); https://doi.org/10.1016/j.bmcl.2018.02.004
  7. J. De La Chapa, M. Valdez, F. Ruiz III, K. Gonzales, W. Mitchell, S.F. McHardy, M. Hart, S.R. Polusani and C.B. Gonzales, Bioorg. Med. Chem., 27, 208 (2019); https://doi.org/10.1016/j.bmc.2018.11.040
  8. N. Kaur, N. Ahlawat, P. Bhardwaj, Y. Verma, P. Grewal and N.K. Jangid, Synthesis of Five-Membered N-Heterocycles using Rh Based Metal Catalysts, Synth. Commun., 50, 137 (2020); https://doi.org/10.1080/00397911.2019.1689271
  9. U. Sharma, G.E. Cozier, E.D. Sturrock and K.R. Acharya, Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme, J. Med. Chem., 63, 5488 (2020); https://doi.org/10.1021/acs.jmedchem.0c00441
  10. S. Kiyonaka, K. Kato, M. Nishida, K. Mio, T. Numaga, Y. Sawaguchi, T. Yoshida, M. Wakamori, E. Mori, T. Numata, M. Ishii, H. Takemoto, A. Ojida, K. Watanabe, A. Uemura, H. Kurose, T. Morii, T. Kobayashi, Y. Sato, C. Sato, I. Hamachi and Y. Mori, Selective and Direct Inhibition of TRPC3 Channels Underlies Biological Activities of a Pyrazole Compound, Proc. Natl. Acad. Sci. USA, 106, 5400 (2009); https://doi.org/10.1073/pnas.0808793106
  11. M. Song, B. Liu, S. Yu, S. He, Y. Liang, S. Li, Q. Chen and X. Deng, New Hydrazone Derivatives of Pyrazole-4-carboxaldehydes Exhibited Anti-inflammatory Properties, Lett. Drug Des. Discov., 17, 502 (2020); https://doi.org/10.2174/1570180816666190731113441
  12. Z. Yang, P. Li and X. Gan, Novel Pyrazole-Hydrazone Derivatives Containing an Isoxazole Moiety: Design, Synthesis, and Antiviral Activity, Molecules, 23, 1798 (2018); https://doi.org/10.3390/molecules23071798
  13. V. Alagarsamy and G. Saravanan, Synthesis and Anticonvulsant Activity of Novel Quinazolin-4(3H)-one Derived Pyrazole Analogs, Med. Chem. Res., 22, 1711 (2013); https://doi.org/10.1007/s00044-012-0169-9
  14. S.A. Galal, A.S. Abdelsamie, S.A. Shouman, Y.M. Attia, H.I. Ali, A. Tabll, R. El-Shenawy, Y.S. El Abd, M.M. Ali, A.E. Mahmoud, A.H. Abdel-Halim, A.A. Fyiad, A.S. Girgis and H.I. El-Diwani, Part I: Design, Synthesis and Biological Evaluation of Novel Pyrazole-Benzimidazole Conjugates as Checkpoint Kinase 2 (Chk2) Inhibitors with Studying their Activities alone and in Combination with Genotoxic Drugs, Eur. J. Med. Chem., 134, 392 (2017); https://doi.org/10.1016/j.ejmech.2017.03.090
  15. A. Messore, A. Corona, V.N. Madia, F. Saccoliti, V. Tudino, A. De Leo, L. Scipione, D. De Vita, G. Amendola, S. Di Maro, E. Novellino, S. Cosconati, M. Métifiot, M.-L. Andreola, P. Valenti, F. Esposito, N. Grandi, E. Tramontano, R. Costi and R. Di Santo, Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase, ACS Med. Chem. Lett., 11, 798 (2020); https://doi.org/10.1021/acsmedchemlett.9b00617
  16. K.M. Pandya, A.H. Patel and P.S. Desai, Development of Antimicrobial, Antimalarial and Antitubercular Compounds Based on a Quinoline-Pyrazole Clubbed Scaffold Derived via Doebner Reaction, Chem. Afr., 3, 89 (2020); https://doi.org/10.1007/s42250-019-00096-5
  17. A. Titi, M. Messali, B.A. Alqurashy, R. Touzani, T. Shiga, H. Oshio, M. Fettouhi, M. Rajabi, F.A. Almalki and T. Ben Hadda, Synthesis, Characterization, X-Ray Crystal Study and Bioctivities of Pyrazole Derivatives: Identification of Antitumor, Antifungal and Antibacterial Pharmacophore Sites, J. Mol. Struct., 1205, 127625 (2020); https://doi.org/10.1016/j.molstruc.2019.127625
  18. W.A. Fadaly, Y.A. Elshaier, E.H. Hassanein and K.R. Abdellatif, New 1,2,4-Triazole/Pyrazole Hybrids Linked to Oxime Moiety as Nitric Oxide Donor Celecoxib Analogs: Synthesis, Cyclooxygenase Inhibition Anti-Inflammatory, Ulcerogenicity, Anti-proliferative Activities, Apoptosis, Molecular Modeling and Nitric Oxide Release Studies, Bioorg. Chem., 98, 103752 (2020); https://doi.org/10.1016/j.bioorg.2020.103752
  19. K.R. Abdellatif, W.A. Fadaly, Y.A. Elshaier, W.A. Ali and G.M. Kamel, Non-Acidic 1,3,4-Trisubstituted-Pyrazole Derivatives as Lonazolac Analogs with Promising COX-2 Selectivity, Anti-inflammatory Activity and Gastric Safety Profile, Bioorg. Chem., 77, 568 (2018); https://doi.org/10.1016/j.bioorg.2018.02.018
  20. J.B. Hirani, M.K. Pandya and S.B. Koradiya, Synthesis of Diverse Fused Tetracyclic Thiazepine-Chalcone Derivatives by Claisen-Schmidt Condensation Reaction and their Antimicrobial Activity, Asian J. Chem., 32, 2860 (2020: https://doi.org/10.14233/ajchem.2020.22867
  21. A.L. Banty, The Antimicrobial Susceptibility test. Illus lea and Febiger, Philadelphia, USA, p. 180 (1976).
  22. H.W. Seeley, P.J. Vandemark and P.J. van Demark, Microbes in Action: A Laboratory Manual of Microbiology (1970).